Standard
Community- Dose
- 1–2 mg GHK-Cu share
- How often
- Once daily
- How long
- 4–6 weeks, then 2–4 weeks off
E.g., 10 units from a 70 mg vial in 3 mL gives about 1.7 mg GHK-Cu and 330 mcg each of BPC-157 and TB-500.
BlendSkin and repair blend
GLOW blend
GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg
- Common dose
- 1–2 mg GHK-Cu share, daily
- Cycle
- 6 weeks on, 3 off
- Vial sizes
- 50 + 10 + 10 mg
- Typical draw
- 10 units50 + 10 + 10 mg with 3 mL
A three-peptide blend built around GHK-Cu, with smaller amounts of BPC-157 and TB-500.
Evidence. No studies of the blend. GHK-Cu has topical human data; BPC-157 and TB-500 are mostly animal data.
Status
GLOW blend isn’t an approved product anywhere. Here is where each part stands.
- GHK-Cu
- Likely banned in sportNot approved as a drug in the US or EU; sold as a cosmetic ingredient (INCI name copper tripeptide-1).
- BPC-157
- Banned in sportNot approved as a drug in the US or EU.
- TB-500
- Banned in sportNot approved as a drug in the US or EU.
Sport status follows the WADA 2026 Prohibited List. Each part’s page has its full status, including US compounding. Checked October 5, 2026.
Protocol
Community
No established protocol. Injections are usually sized by the GHK-Cu share (1–2 mg), which carries about 200–400 mcg each of BPC-157 and TB-500.
- Frequency
- Once daily
- Route
- Subcutaneous injection
- Cycle
- 4–8 weeks on, 2–4 weeks off.
6 weeks on, 3 off, shown over 26 weeks
Common protocols
The ways GLOW blend is most often run, each tagged with where it comes from.
Separate vials
Community- Dose
- GHK-Cu 1–2 mg; BPC-157 250–500 mcg; TB-500 2–2.5 mg
- How often
- GHK-Cu and BPC-157 daily; TB-500 twice weekly
- How long
- 4–8 weeks
Same three peptides without the fixed ratio. See each component entry.
Taking it
Where it goes
Under the skin, usually the belly, rotating spots. GHK-Cu can sting, so inject slowly with the vial at room temperature.
If you miss a dose
No published guidance, and the guides checked don’t address it. Skip it and take the next daily dose on schedule; don’t double up.
What to expect
- Weeks 1–2
Guides describe less inflammation early on, plus some tiredness from TB-500. Anecdotal.
Community - Weeks 3–8
First skin changes (firmer feel, smoother texture) described from week 3–4, more visible by weeks 5–8. Anecdotal.
Community
Side effects and what to do
Injection-site redness, sting or warmth (community)
Mostly from GHK-Cu. Clears in minutes to hours; rotate sites. Reassess if it gets worse over the first week.
Headache or tiredness (community)
Usually early and brief. See TB-500.
Flushing or a metallic taste (community)
Linked to the copper peptide and short-lived. See GHK-Cu.
Stop and get medical help
Hives, face or throat swelling, trouble breathing, chest pain or fainting; spreading redness, heat, pus or fever at a site; or any new lump. See each component.
Tracking and pairing
Worth tracking
- Injection-site reactions
- Skin changes, judged over 4–8 weeks
Often paired with
- KPV
Adding it gives the KLOW blend, aimed at inflammation too.
Mixing your vial
| Vial | Water | Draw | Volume | Each dose contains | Action |
|---|---|---|---|---|---|
| 50 + 10 + 10 mg | 3 mL | 10 units | 0.10 mL | 1.67 mg GHK-Cu 333 mcg BPC-157 333 mcg TB-500 |
A blue solution is normal (copper). GHK-Cu stings at high strength, so this blend is usually mixed with 3 mL. At 3 mL, 10 units carries about 1.67 mg of GHK-Cu and 333 mcg each of BPC-157 and TB-500.
Storage
Powder: −20 °C, protected from light. Mixed: 2–8 °C.
Cautions
- Carries the cautions of all three peptides.
- Avoid with Wilson’s disease or other copper-metabolism disorders.
Questions
What is GLOW blend?
A three-peptide blend built around GHK-Cu, with smaller amounts of BPC-157 and TB-500.
Is GLOW blend an approved drug?
No. It is a fixed mix of GHK-Cu, BPC-157 and TB-500, and the blend itself hasn’t been approved or studied. The status section above shows where each part stands.
What is the usual GLOW blend dose?
From community reports, not established: No established protocol. Injections are usually sized by the GHK-Cu share (1–2 mg), which carries about 200–400 mcg each of BPC-157 and TB-500. These are the amounts sources reference, not recommendations.
How much water do I mix GLOW blend with?
There’s no single right amount, because the water only sets the strength. With 3 mL of bacteriostatic water in a 50 + 10 + 10 mg vial, the strength is 23.33 mg/mL, so a 10-unit draw holds 1.67 mg GHK-Cu, 333 mcg BPC-157 and 333 mcg TB-500. More water makes small doses easier to measure. The dose chart above shows other volumes.
How should GLOW blend be stored?
Powder: −20 °C, protected from light. Mixed: 2–8 °C.
Is GLOW blend banned in sport?
Yes. A blend takes the strictest status of its parts: GHK-Cu is likely banned, BPC-157 is banned and TB-500 is banned.
Has GLOW blend been studied in people?
Not as a blend. Any human data come from studies of its parts, listed on their own pages.
Sources
No primary source establishes a dose for this blend. The ranges above reflect community reports, and the component pages list sources for each peptide.
Doses tagged Community come from public dosing guides and user reports, checked against at least two of them. Those sites aren’t named here because many of them sell peptides or earn commissions on them.